Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Thyroid Gland Adenocarcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Endocrine Neoplasm
Endocrine Carcinoma
Thyroid Gland Adenocarcinoma

Subtype

Thyroid Gland Adenocarcinoma

CI-CAN-00004120Explore in graph →

43 active trials3 approved drugs28 evidence items

NCIt: C27380
DOID: 0080524

Overview
Statistics
Survival
Genomics5
Variants & evidence28
Drugs5
Trials195
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

195 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 17
Ph III recruiting: 4
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

StatusAll Active (any)Completed 78 Recruiting 32 Unknown 28 Active Not Recruiting 24 Not Yet Recruiting 16 Terminated 13 Enrolling By Invitation 1 Suspended 1 Approved For Marketing 1 Withdrawn 1

PhaseAll Early Phase 1 2 N/A 50 Phase 1 17 Phase 2 56 Phase 3 4 Phase 4 2

No study matches these filters